Presentation is loading. Please wait.

Presentation is loading. Please wait.

Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O

Published byMarvin Lynch Modified over 5 years ago

Similar presentations

Presentation on theme: "Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O"— Presentation transcript:

1 Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three 
Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O. Clayton, MSc, Colin F. Robertson, MD, M. Innes Asher, MBChB  Journal of Allergy and Clinical Immunology  Volume 124, Issue 6, Pages e23 (December 2009) DOI: /j.jaci Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 World maps showing prevalence of current symptoms of eczema for the age group 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Blue squares indicate prevalence of less than 5%, green circles indicate prevalence of 5% to less than 10%, yellow diamonds indicate prevalence of 10% to less than 15%, and red stars indicate prevalence of 15% or more. Europe is shown in greater detail in the inset section. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Ranked prevalence plots of current symptoms of eczema for the age group 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 2 Ranked prevalence plots of current symptoms of eczema for the age group 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Questions on eczema symptoms used in ISAAC Phase Three.
Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 World maps showing prevalence of current symptoms of severe eczema for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Blue squares indicate prevalence of less than 1%, green circles indicate prevalence of 1% to less than 1.5%, yellow diamonds indicate prevalence of 1.5% to less than 2%, and red stars indicate prevalence of 2% or more. Europe is shown in greater detail in the inset section. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Ranked prevalence plots of current symptoms of eczema for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Regions are ordered by average prevalence. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

8 Ranked prevalence plots of current symptoms of severe eczema for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

9 Ranked prevalence plots of current symptoms of severe eczema for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

10 Ranked prevalence plots of lifetime reported “eczema” for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

11 Ranked prevalence plots of lifetime reported “eczema” for the age groups 6 to 7 years (A) and 13 to 14 years (B). Each symbol represents a center. Countries are ordered by average prevalence. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

12 Scatter plots illustrating prevalence by sex for current symptoms of eczema (A), current symptoms of severe eczema (B), and lifetime reported “eczema” (C) for the age group 6 to 7 years, and current symptoms of eczema (D), current symptoms of severe eczema (E), and lifetime reported “eczema” (F) for the age group 13 to 14 years. Each symbol represents a center. The line of equality is shown on each plot. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

13 Scatter plots illustrating prevalence by sex for current symptoms of eczema (A), current symptoms of severe eczema (B), and lifetime reported “eczema” (C) for the age group 6 to 7 years, and current symptoms of eczema (D), current symptoms of severe eczema (E), and lifetime reported “eczema” (F) for the age group 13 to 14 years. Each symbol represents a center. The line of equality is shown on each plot. Journal of Allergy and Clinical Immunology  , e23DOI: ( /j.jaci ) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O"

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada Moshe Ben-Shoshan, MD, Daniel W. Harrington, MA,

A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada Moshe Ben-Shoshan, MD, Daniel W. Harrington, MA,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.

Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
What drives prescription patterns in pediatric asthma management?

What drives prescription patterns in pediatric asthma management?
Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study  Anna.

Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study  Anna.
Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 

Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Ann-Marie M. Schoos, MD, PhD, Jacob D

Ann-Marie M. Schoos, MD, PhD, Jacob D
Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood  Hywel Williams, PhDa,

Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood  Hywel Williams, PhDa,
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 

Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma  Christine L.M. Joseph,

Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma  Christine L.M. Joseph,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,

Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,
Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study  Anna.

Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study  Anna.
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Children with allergic and nonallergic rhinitis have a similar risk of asthma  Bo Lund Krogsgaard Chawes, MD, Klaus Bønnelykke, MD, PhD, Eskil Kreiner-Møller,

Children with allergic and nonallergic rhinitis have a similar risk of asthma  Bo Lund Krogsgaard Chawes, MD, Klaus Bønnelykke, MD, PhD, Eskil Kreiner-Møller,

Similar presentations

Ads by Google